Study in a Sentence: A new multi-component, transformer-based, open-source AI model, Boltz-2, predicts protein–drug binding ...

Meeting Completion Marks Major Step Toward Phase 3 AD04 Trial Launch Strategic Partnership Discussions Expected Following the ...

At a Glance Computational modeling & simulation is another tool in the engineer's testing toolbox, says MD&M West speaker Mark Burchnall. MD&M West will be held February 4-6, 2025. Burchnall, an ...

Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables Nov. 13, 2024 8:30 AM ET Simulations Plus, Inc. (SLP) ...

Certara the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced that its Simcyp physiologically-based pharmacokinetic (PBPK) ...

According to this report the global drug modeling software biopharmaceutical market is expected to reach US$ 11,299.85 million by 2027 from US$ 6,205.22 million in 2019; it is estimated to grow at ...

The project brought together expertise in chemistry, drug discovery, quantum mechanics, and supercomputing, with the Oak Ridge National Laboratory, leading semiconductor company AMD, and deep-tech ...

In 2001, Hwang et al. developed a numerical model to accompany laboratory testing of bovine aorta.2 They were able to capture anisotropic diffusive properties in the arterial wall, as well as ...

Certara today announced the launch of its industry-leading Phoenix 8.0 PK/PD modeling and simulation software for drug development scientists.